Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Three out of seven (42.9%) cycles required progestogen induced withdrawal before commencement of rosiglitazone ; this reduced to 3 out of 21 cycles after treatment (14.3%) (P = 0.14).”